Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Clotting factor concentrates].

M Barthels¹, W Schramm

¹Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Germany.

Hamostaseologie

|November 5, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary data.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

Same author

Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Same author

Socioeconomic impact of haemophilia care: results of a pilot study.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Research in haemophilia B--approaching the request for high evidence levels in a rare disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Same author

Risks and challenges of orthopaedic invasive interventions in haemophilia in a low-resource country. A single-center experience.

Hamostaseologie·2014

Same author

[Prophylactic factor substitution in severe haemophilia A. Economic assessment in adult patients].

Hamostaseologie·2014

This survey reviews plasma-derived and recombinant coagulation factor concentrates, emphasizing careful consideration of their benefits versus potential short and long-term side effects for patients.

Area of Science:

Hematology
Pharmacology

Context:

Focuses on coagulation factor concentrates, essential for managing bleeding disorders.
Highlights the critical role of these therapies in patient care.

Purpose:

To survey the indications and clinical use of plasma-derived and recombinant coagulation factor concentrates.
To inform careful patient management by balancing treatment efficacy with potential adverse effects.

Summary:

Reviews the application of plasma-derived and recombinant coagulation factor concentrates.
Emphasizes the need for a risk-benefit assessment in individual patient cases.
Discusses both therapeutic effectiveness and potential side effects.

Impact:

Aids clinicians in optimizing the use of coagulation factor therapies.

Related Experiment Videos

Promotes informed decision-making regarding substitution therapy.

Contributes to improved patient safety and treatment outcomes.